1257705-09-1

Basic information

• Product Name: 5-[4-(1,1-dioxothiomorpholin-4-ylmethyl)-phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine
• Synonyms: 5-[4-(1,1-dioxothiomorpholin-4-ylmethyl)-phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine
• CAS NO: 1257705-09-1
• Molecular Weight: 357.436
• Mol File: 1257705-09-1.mol
• Article Data: 6

Chemical Properties

• Density: 1.48±0.1 g/cm3(Predicted)
• CAS DataBase Reference: 5-[4-(1,1-dioxothiomorpholin-4-ylmethyl)-phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-[4-(1,1-dioxothiomorpholin-4-ylmethyl)-phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine(1257705-09-1)
• EPA Substance Registry System: 5-[4-(1,1-dioxothiomorpholin-4-ylmethyl)-phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine(1257705-09-1)

Safety Data

• Hazardous Substances Data: 1257705-09-1(Hazardous Substances Data)

Upstream product

• 1092563-25-1 4-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzyl]-thiomorpholine-1,1-dioxide 
• 1010120-55-4 5-Bromo-[1,2,4]Triazolo[1,5-a]pyridine-2-ylamine 
• 1206161-97-8 N-(5-{4-[(1,1-dioxo-1λ⁶-thiomorpholin-4-yl)methyl]phenyl}-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide 
• 19798-81-3 2-Amino-6-bromopyridine 
• 1010120-59-8 ethyl N-[(6-bromopyridin-2-yl)carbamothioyl]carbamate 
• 344331-90-4 tert-butyl 6-bromopyridin-2-ylcarbamate 
• 159603-71-1 t-butyl N-(6-chloro-2-pyridinyl)carbamate 
• 747413-23-6 4-[(4-boronophenyl)methyl]thiomorpholine 1,1-dioxide 
• 138500-85-3 4-bromomethylphenylboronic acid pinacol ester 

Downstream Products

• 1206161-97-8 N-(5-{4-[(1,1-dioxo-1λ⁶-thiomorpholin-4-yl)methyl]phenyl}-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide 

Relevant articles and documents

PROCESSES FOR THE PREPARATION OF FILGOTINIB

The present invention relates to processes for the preparation of Filgotinib. The present invention relates to novel processes for the preparation of filgotinib. The present invention also relates to novel intermediates for the preparation of filgotinib.

[1,2,4]triazol[1,5-a] pyridine compound as well as preparation method and medical application thereof

The invention relates to a [1,2,4]triazol[1,5-a] pyridine compound as well as a preparation method and medical application thereof, in particular to a compound shown in a general formula I, a preparation method thereof, a pharmaceutical composition contai

AMINOTRIAZOLOPYRIDINE FOR USE IN THE TREATMENT OF INFLAMMATION, AND PHARMACEUTICAL COMPOSITIONS THEREOF

The present invention relates to the novel medical use of the compound according to Formula I, in particular in the treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving impair